ArticleInternational orthopaedics2015
A 21% conversion rate to total knee arthroplasty of a first-generation patellofemoral prosthesis at a mean follow-up of 9.7 years.
Article in International orthopaedics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Failure modes of patellofemoral arthroplasty-registries vs. clinical studies: a systematic review.Acta orthopaedica · 2019Pooled it
- Survivorship and functional outcomes of patellofemoral arthroplasty: a systematic review.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2017Pooled it
- Systematic review and meta-analysis of implant-specific outcomes in inlay and onlay patellofemoral arthroplasty for isolated patellofemoral osteoarthritis.Journal of experimental orthopaedics · 2025Review
- Outcomes After Patellofemoral Arthroplasty With the Arthrex iBalance-A Third Generation Implant.Arthroplasty today · 2025Article
- The landscape of patellofemoral arthroplasty research: a bibliometric analysis.Arthroplasty (London, England) · 2023Article
- Patella alta and patellar subluxation might lead to early failure with inlay patello-femoral joint arthroplasty.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2019Article
- Advances in Patellofemoral Arthroplasty.Current reviews in musculoskeletal medicine · 2018Review
- Patellofemoral Arthroplasty.Ochsner journal · 2018Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the mid- to long-term results of the Richards' type II patellofemoral arthroplasty (PFA) in terms of functional scores, number and type of complications, patient satisfaction and survival.
methodsWe retrospectively studied patients that received a Richards' type II PFA at our institution between 1998 and 2007. Patients with a functioning PFA at the time of this study were evaluated. Outcomes included survival rates with endpoint loss of prosthesis, number and type of complications, Knee Society Scores (KSS) and Visual Analogue Scale (VAS) for pain. In addition, patients were asked how surgery influenced their original symptoms.
resultsTwenty-four patients (33 prostheses) were included. Follow-up ranged from 2.2 to 18.8 years with a mean of 9.7 years. Survival at 10 years was 73% (95% CI, 57-93%). Median KSS score was 163 (range, 110-200). Median VAS Pain was 30 (range, 0-80) and VAS Satisfaction median was 90 (range, 50-100). Thirteen (62%) PFAs were rated excellent, six (28%) as good and two (10%) as fair. Twelve (36%) of the cases required further surgery within 4 years after implantation. Seven of these (21%) were converted to TKA after a mean time of 5.5 years, five out of seven were converted because of ongoing tibiofemoral osteoarthritis (TFOA).
conclusionsWe found a rate of 21% (7/33) conversion of the Richards' II PFA to TKA after a mean of 5.5 years; 71% (5/7) of cases were because of TFOA. We strongly advise not to use PFA if there is any sign of joint disease in other compartments than patellofemoral.
Indexed as
Identifiers
26231494What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.